

He’s been on a tear trying to educate other doctors about POTS and MCAS, and the education began early in the case report. The authors didn’t only illuminate a novel treatment regimen: they applied it to two conditions that many doctors either don’t know about (POTS) or may not believe exists (mast cell activation syndrome (MCAS)).īrent Goodman at the Mayo Clinic in Phoenix was the MD associated with this case. “Novel treatment (new drug/intervention established drug/procedure in new situation)” Emblazoned across the top of every page of the case report, “ Successful treatment of postural orthostatic tachycardia and mast cell activation syndromes using naltrexone, immunoglobulin and antibiotic treatment“, That’s what happened here but this wasn’t your normal case report. Short of participating in a study, though, the best way to spark interest in it is to write up a case report and get it published. They can tell their colleagues or speak about it at a conference. If a doctor wants to spread news of a better treatment approach, there are several things they can do. The light bulb came on for this complex patient after she tried an over-the-counter medication.
